[Bacterial Sialadenitis]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2010 Mar 6

PMID 20204311

Citations 1

Authors

H Maier

M Tisch

Affiliations

Soon will be listed here.

Abstract

The parotid gland is most commonly involved in bacterial sialadenitis. Predisposing factors for the ductally ascending infection, are dehydration, xerogenic drugs and salivary gland diseases associated with ductal obstructions or reduced saliva secretion. In the majority of cases the infection is caused by Staphylococcus aureus. However, a variety of other aerobic and anaerobic pathogens may be involved. Besides hydration, elimination of ductal obstruction and stimulation of saliva flow antibiotic treatment according to antibiogram is essential. In selected cases, for instance if a salivary gland abscess develops, surgical treatment may become necessary. Actinomycosis, tuberculosis and atypical mycobacteriosis are rare variations of bacterial sialadenitis which clinically may resemble a salivary gland tumor.

Citing Articles

Does fasting during Ramadan increase the risk of the development of sialadenitis?.

Joachim M, Ghantous Y, Zaaroura S, Alkeesh K, Zoabi T, Abu El-Naaj I BMC Oral Health. 2020; 20(1):156.

PMID: 32471399 PMC: 7260764. DOI: 10.1186/s12903-020-01139-x.

References

Maier H, Attallah M, Junemann K . [Facial paralysis in chronic nonspecific inflammation of the parotid]. HNO. 1990; 38(1):38-40. View

Fox P . Salivary gland involvement in HIV-1 infection. Oral Surg Oral Med Oral Pathol. 1992; 73(2):168-70. DOI: 10.1016/0030-4220(92)90190-2. View

Stanley R, Fernandez J, Peppard S . Cervicofacial mycobacterial infections presenting as major salivary gland disease. Laryngoscope. 1983; 93(10):1271-5. DOI: 10.1002/lary.1983.93.10.1271. View

Al-Serhani A . Mycobacterial infection of the head and neck: presentation and diagnosis. Laryngoscope. 2002; 111(11 Pt 1):2012-6. DOI: 10.1097/00005537-200111000-00027. View

Williams R . Mycobacterium marches back. J Laryngol Otol. 1995; 109(1):5-13. DOI: 10.1017/s0022215100129123. View

Maier W, Strutz J . Concentration of cephalosporins in tissues of the head and neck after parenteral infusion. Chemotherapy. 1995; 41(6):421-6. DOI: 10.1159/000239377. View

Arduino P, Carrozzo M, Pentenero M, Bertolusso G, Gandolfo S . Non-neoplastic salivary gland diseases. Minerva Stomatol. 2006; 55(5):249-70. View

Tevere V, Hewitt P, Dare A, Hocknell P, Keen A, Spadoro J . Detection of Mycobacterium tuberculosis by PCR amplification with pan-Mycobacterium primers and hybridization to an M. tuberculosis-specific probe. J Clin Microbiol. 1996; 34(4):918-23. PMC: 228917. DOI: 10.1128/jcm.34.4.918-923.1996. View

Perlman D, Salomon N . Tuberculosis in patients with human immunodeficiency virus infection. Semin Respir Infect. 2000; 14(4):344-52. View

10.

Al-Dajani N, Wootton S . Cervical lymphadenitis, suppurative parotitis, thyroiditis, and infected cysts. Infect Dis Clin North Am. 2007; 21(2):523-41, viii. DOI: 10.1016/j.idc.2007.03.004. View

11.

Maier H, Sziegoleit A, Merck S . Penetration of ciprofloxacin into parotid gland tissue and parotid saliva. Arzneimittelforschung. 1987; 37(7):797-8. View

12.

Kim Y, Jeong W, Jung K, Sung M, Kim K, Kim C . Diagnosis of major salivary gland tuberculosis: experience of eight cases and review of the literature. Acta Otolaryngol. 2005; 125(12):1318-22. DOI: 10.1080/00016480510012246. View

13.

Lang-Roth R, Schippers C, Eckel H . [Cervical actinomycosis. A rare differential diagnosis of parotid tumor]. HNO. 1998; 46(4):354-8. DOI: 10.1007/s001060050252. View

14.

Reede D, Bergeron R . Cervical tuberculous adenitis: CT manifestations. Radiology. 1985; 154(3):701-4. DOI: 10.1148/radiology.154.3.3969473. View

15.

Dayan D, Vered M, Paz T, Buchner A . Aging of human palatal salivary glands: a histomorphometric study. Exp Gerontol. 2000; 35(1):85-93. DOI: 10.1016/s0531-5565(99)00079-0. View

16.

Hogan M, Price D, Burrage K, Pushpanathan C . Atypical mycobacterial cervical lymphadenitis with extensive local spread: a surgical disease. Pediatr Surg Int. 2005; 21(9):758-60. DOI: 10.1007/s00383-005-1491-9. View

17.

Willenborg K, Gotz F, Klein R, Lenarz T, Stover T . [Tuberculosis in the parotid gland in HIV infection]. Laryngorhinootologie. 2008; 87(6):420-2. DOI: 10.1055/s-2007-995462. View

18.

Henderson L, Muir M, Mills P, Spence E, Fox R, McCruden E . Oral health of patients with hepatitis C virus infection: a pilot study. Oral Dis. 2002; 7(5):271-5. DOI: 10.1034/j.1601-0825.2001.00695.x. View

19.

Jervis P, Lee J, Bull P . Management of non-tuberculous mycobacterial peri-sialadenitis in children: the Sheffield otolaryngology experience. Clin Otolaryngol Allied Sci. 2001; 26(3):243-8. DOI: 10.1046/j.0307-7772.2001.00465.x. View

20.

Maier H, Zerfowski M, Schlegel P . [Excretion of beta-lactam antibiotics in human parotid saliva]. HNO. 1991; 39(3):102-7. View